Latest filing published 24 Jun 2026 for Mabwell (Shanghai) Bioscience Co., Ltd. - B - H Shares.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
LIU Datao: trading record in brief
All filings by LIU Datao on record concern Mabwell (Shanghai) Bioscience Co., Ltd. - B, in the capacity of chief executive. In total, 2 filings cover trades dated from 28 April 2026 to 18 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 24 June 2026 came the latest disclosure, a transaction in Mabwell (Shanghai) Bioscience Co., Ltd. - B. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to LIU Datao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.